FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

RC Turner

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Islets of Langerhans

Activities & Behaviors

Fasting

Concepts & Ideas

Procedures

Geographic Areas

Great Britain

Devices

Glucose Clamp Technique

Co-author Network

Publications

TOP 3
Anna L Gloyn; Y Hashim; Stephen J H Ashcroft; R Ashfield; Steven Wiltshire; RC Turner
Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
Irene M Stratton; Eva M Kohner; Steve Aldington; RC Turner; Rury R Holman; Irene Stratton; David R Matthews
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
C M MacNamara; BA Barrow; Irene Stratton; Jonathan C Levy; Anne Clark; RC Turner
Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of RC Turner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Anna L Gloyn; Y Hashim; Stephen J H Ashcroft; R Ashfield; Steven Wiltshire; RC Turner
Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
Diabetic medicine : a journal of the British Diabetic Association 2001;18(3):206-12.
2001: Irene M Stratton; Eva M Kohner; Steve Aldington; RC Turner; Rury R Holman; Irene Stratton; David R Matthews
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Diabetologia 2001;44(2):156-63.
2000: C M MacNamara; BA Barrow; Irene Stratton; Jonathan C Levy; Anne Clark; RC Turner
Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
Diabetes research and clinical practice 2000;50(2):117-26.
2000: Amanda I Adler; Irene M Stratton; H A W Neil; J S Yudkin; David R Matthews; Carole A Cull; A D Wright; RC Turner; Rury R Holman
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
BMJ (Clinical research ed.) 2000;321(7258):412-9.
2000: Irene M Stratton; Amanda I Adler; H A W Neil; David R Matthews; Irene Stratton; Carole A Cull; D Hadden; RC Turner; Rury R Holman
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
BMJ (Clinical research ed.) 2000;321(7258):405-12.
2000: Irene Stratton; Irene M Stratton; Carole A Cull; Valeria Frighi; E A Eeley; David R Matthews; Rury R Holman; RC Turner; H A W Neil
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(7):518-23.
2000: Adji Widjaja; Jonathan C Levy; R J Morris; K N Frayn; S M Humphreys; R Horn; Alexander von zur Mühlen; RC Turner; G Brabant
Determinants of within-subject variation of fasting serum leptin concentrations in healthy subjects.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(3):208-13.
1999: Amanda I Adler; H A W Neil; Irene Stratton; Rury R Holman; RC Turner
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47).
American heart journal 1999;138(5 Pt 1):S353-9.
1999: MP Hermans; Jonathan C Levy; R J Morris; RC Turner
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.
Diabetes 1999;48(9):1779-86.
1999: Eva M Kohner; Irene M Stratton; Steve Aldington; RC Turner; David R Matthews
Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Diabetologia 1999;42(9):1107-12.
1999: RC Turner; Carole A Cull; Valeria Frighi; Rury R Holman
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
JAMA : the journal of the American Medical Association 1999;281(21):2005-12.
1999: MP Hermans; Jonathan C Levy; R J Morris; RC Turner
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes.
Diabetologia 1999;42(6):678-87.
1999: Rury R Holman; Carole A Cull; RC Turner
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
Diabetes care 1999;22(6):960-4.
1999: Timothy Davis; H Millns; Irene M Stratton; Rury R Holman; RC Turner
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Archives of internal medicine 1999;159(10):1097-103.
1999: Amanda I Adler; RC Turner
The diabetes prevention program.
Diabetes care 1999;22(4):543-5.
1999: Adji Widjaja; R J Morris; Jonathan C Levy; K N Frayn; Irene Stratton; RC Turner
Within- and between-subject variation in commonly measured anthropometric and biochemical variables.
Clinical chemistry 1999;45(4):561-6.
1999: Andrew Farmer; Jonathan C Levy; RC Turner
Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(3):233-7.
1999: RC Turner; Rury R Holman
Metformin and risk of cardiovascular disease.
Cardiology 1999;91(3):203-4.
1999: Joanne T E Shaw; D M Purdie; H A W Neil; Jonathan C Levy; RC Turner
The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus.
Diabetologia 1999;42(1):24-7.
1998: Joanne T E Shaw; Jonathan C Levy; RC Turner
The relationship between the insulin resistance syndrome and insulin sensitivity in the first-degree relatives of subjects with non-insulin dependent diabetes mellitus.
Diabetes research and clinical practice 1998;42(2):91-9.
1998: J Rachman; M J Payne; Jonathan C Levy; BA Barrow; Rury R Holman; RC Turner
Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
Diabetes care 1998;21(5):810-6.
1998: David R Matthews; Carole A Cull; Irene M Stratton; Rury R Holman; RC Turner
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(4):297-303.
1998: RC Turner; H Millns; H A W Neil; Irene M Stratton; Irene Stratton; David R Matthews; Rury R Holman
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
BMJ (Clinical research ed.) 1998;316(7134):823-8.
1998: Eva M Kohner; Steve Aldington; Irene M Stratton; S E Manley; Rury R Holman; David R Matthews; RC Turner
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.
Archives of ophthalmology 1998;116(3):297-303.
1997: S Karunakaran; MS Hammersley; RJ Morris; RC Turner; Rury R Holman
The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose.
Metabolism: clinical and experimental 1997;46(12 Suppl 1):56-60.
1997: P A Dyson; MS Hammersley; RJ Morris; Rury R Holman; RC Turner
The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose.
Metabolism: clinical and experimental 1997;46(12 Suppl 1):50-5.
1997: MS Hammersley; L C Meyer; RJ Morris; Irene Stratton; RC Turner; Rury R Holman
The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.
Metabolism: clinical and experimental 1997;46(12 Suppl 1):44-9.
1997: A T Hattersley; P M Clark; R Page; Jonathan C Levy; L Cox; C N Hales; RC Turner
Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations.
Diabetologia 1997;40(11):1367-8.
1997: Carole A Cull; Irene Stratton; Irene M Stratton; H A W Neil; I S Ross; Rury R Holman; RC Turner; David R Matthews
Approach to maintaining comparability of biochemical data during long-term clinical trials.
Clinical chemistry 1997;43(10):1913-8.
1997: J Rachman; Jonathan C Levy; BA Barrow; Irene Stratton; RC Turner
Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
Diabetes 1997;46(10):1557-62.
1997: Timothy Davis; Irene M Stratton; C J Fox; Rury R Holman; RC Turner
U.K. Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM.
Diabetes care 1997;20(9):1435-41.
1997: RC Turner; H Millns; Rury R Holman
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
Diabetologia 1997;40 Suppl 2():S121-2.
1997: M G Warren-Perry; Irene Stratton; D Ostrega; Kenneth S Polonsky; S Mussett; P Brown; RC Turner
A novel point mutation in the insulin gene giving rise to hyperproinsulinemia.
The Journal of clinical endocrinology and metabolism 1997;82(5):1629-31.
1997: H Inoue; J Ferrer; M Warren-Perry; Y Zhang; H Millns; RC Turner; Steven C Elbein; Carol Hampe; Brian K Suarez; N Inagaki; S Seino; M Alan Permutt
Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.
Diabetes 1997;46(3):502-7.
1997: J Rachman; BA Barrow; Jonathan C Levy; RC Turner
Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
Diabetologia 1997;40(2):205-11.
1997: P J Saker; Andrew T Hattersley; BA Barrow; MS Hammersley; Virginia Horton; M D Gillmer; RC Turner
UKPDS 21: low prevalence of the mitochondrial transfer RNA gene (tRNA(Leu(UUR))) mutation at position 3243bp in UK Caucasian type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(1):42-5.
1996: Y Zhang; N Wat; Irene M Stratton; M G Warren-Perry; M Orho; L Groop; RC Turner
UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Diabetologia 1996;39(12):1505-11.
1996: PJ Saker; Andrew T Hattersley; BA Barrow; MS Hammersley; J A McLellan; Y M Dennis Lo; R J Olds; M D Gillmer; Rury R Holman; RC Turner
High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population.
Diabetologia 1996;39(11):1325-8.
1996: J Rachman; F M Gribble; BA Barrow; Jonathan C Levy; K D Buchanan; RC Turner
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Diabetes 1996;45(11):1524-30.
1996: RC Turner; Rury R Holman
The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group.
Annals of medicine 1996;28(5):439-44.
1996: RC Turner; Jonathan C Levy
Notes on the GENNID Study.
Diabetes care 1996;19(8):892-5.
1996: E A Eeley; Irene M Stratton; D R Hadden; RC Turner; Rury R Holman
UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(7):656-62.
1996: M G Warren-Perry; M Stoffel; PJ Saker; Y Zhang; L J Brown; M J MacDonald; RC Turner
Mitochondrial FAD-glycerophosphate dehydrogenase and G-protein-coupled inwardly rectifying K+ channel: No evidence for linkage in maturity-onset diabetes of the young or NIDDM.
Diabetes 1996;45(5):639-41.
1995: C R Dudley; Bernard Keavney; Irene M Stratton; RC Turner; Peter J Ratcliffe
U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM.
Kidney international 1995;48(6):1907-11.
1995: Y Zhang; M Warren-Perry; PJ Saker; Andrew T Hattersley; A D Mackie; J D Baird; R H Greenwood; M Stoffel; G I Bell; RC Turner
Candidate gene studies in pedigrees with maturity-onset diabetes of the young not linked with glucokinase.
Diabetologia 1995;38(9):1055-60.
1995: Rury R Holman; RC Turner
Insulin therapy in type II diabetes.
Diabetes research and clinical practice 1995;28 Suppl():S179-84.
1995: RC Turner; Rury R Holman
Lessons from UK prospective diabetes study.
Diabetes research and clinical practice 1995;28 Suppl():S151-7.
1995: Bernard Keavney; C R Dudley; Irene M Stratton; Rury R Holman; David R Matthews; Peter J Ratcliffe; RC Turner
UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
Diabetologia 1995;38(8):948-52.
1995: J A McLellan; BA Barrow; Jonathan C Levy; MS Hammersley; Andrew T Hattersley; M D Gillmer; RC Turner
Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
Diabetologia 1995;38(6):693-8.
1995: J Rachman; RC Turner
Drugs on the horizon for treatment of type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(6):467-78.
1995: Y Zhang; M Warren-Perry; H Sakura; John P Adelman; M Stoffel; G I Bell; F M Ashcroft; RC Turner
No evidence for mutations in a putative beta-cell ATP-sensitive K+ channel subunit in MODY, NIDDM, or GDM.
Diabetes 1995;44(5):597-600.
1995: R C Page; Andrew T Hattersley; Jonathan C Levy; BA Barrow; P Patel; D Lo; james wainscoat; M A Permutt; G I Bell; RC Turner
Clinical characteristics of subjects with a missense mutation in glucokinase.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(3):209-17.
1995: RC Turner; Andrew T Hattersley; Joanne T E Shaw; Jonathan C Levy
Type II diabetes: clinical aspects of molecular biological studies.
Diabetes 1995;44(1):1-10.
1995: Virginia Horton; M Bunce; D R Davies; RC Turner; Y M Dennis Lo
HLA typing for DR3 and DR4 using artificial restriction fragment length polymorphism PCR from archival DNA.
Journal of clinical pathology 1995;48(1):33-6.
1994: J T Cook; D C Shields; R C Page; Jonathan C Levy; Andrew T Hattersley; J A Shaw; H A W Neil; james wainscoat; RC Turner
Segregation analysis of NIDDM in Caucasian families.
Diabetologia 1994;37(12):1231-40.
1994: R C Page; Joseph Levy; RC Turner
Obesity associated insulin resistance occurs in hypopituitary subjects.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(9):862-5.
1994: Y Zhang; J T Cook; Andrew T Hattersley; R Firth; PJ Saker; M Warren-Perry; M Stoffel; RC Turner
Non-linkage of the glucagon-like peptide 1 receptor gene with maturity onset diabetes of the young.
Diabetologia 1994;37(7):721-4.
1994: RC Turner
[Principles of the prospective study on diabetes at Royaume-Uni].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1994;():101-10.
1993: J T Cook; R C Page; Stephen O'Rahilly; J Levy; Rury Holman; BA Barrow; Andrew T Hattersley; A G Shaw; james wainscoat; RC Turner
Availability of type II diabetic families for detection of diabetes susceptibility genes.
Diabetes 1993;42(10):1536-43.
1993: Andrew T Hattersley; PJ Saker; J T Cook; Irene M Stratton; P Patel; M A Permutt; RC Turner; james wainscoat
Microsatellite polymorphisms at the glucokinase locus: a population association study in Caucasian type 2 diabetic subjects.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(8):694-8.
1993: J P Hosker; M A Burnett; David R Matthews; RC Turner
Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetes.
Metabolism: clinical and experimental 1993;42(9):1116-20.
1993: R C Page; E K Walravens; Jonathan C Levy; Irene M Stratton; RC Turner
Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk white groups.
Metabolism: clinical and experimental 1993;42(8):932-8.
1993: RC Turner; Jonathan C Levy; A Clark
Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms.
The Quarterly journal of medicine 1993;86(7):413-7.
1993: J T Cook; R C Page; Jonathan C Levy; MS Hammersley; E K Walravens; RC Turner
Hyperglycaemic progression in subjects with impaired glucose tolerance: association with decline in beta cell function.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(4):321-6.
1993: Andrew T Hattersley; RC Turner
Mutations of the glucokinase gene and type 2 diabetes.
The Quarterly journal of medicine 1993;86(4):227-32.
1993: R C Page; K E Harnden; N K Walravens; C Onslow; P Sutton; Jonathan C Levy; D T Hockaday; RC Turner
'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
The Quarterly journal of medicine 1993;86(3):145-54.
1993: Andrew T Hattersley; PJ Saker; P Patel; Y M Dennis Lo; R Page; Stephen O'Rahilly; RC Turner; M A Permutt; james wainscoat
Linkage of maturity-onset diabetes of the young to the glucokinase gene--evidence of genetic heterogeneity.
Biochemical Society transactions 1993;21(1):24S.
1993: J T Cook; Jonathan C Levy; R C Page; J A Shaw; Andrew T Hattersley; RC Turner
Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects.
BMJ (Clinical research ed.) 1993;306(6873):302-6.
1993: Jonathan C Levy; P M Clark; C N Hales; RC Turner
Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response.
Diabetes 1993;42(1):162-9.
1993: J T Cook; Andrew T Hattersley; Jonathan C Levy; P Patel; james wainscoat; T D Hockaday; RC Turner
Distribution of type II diabetes in nuclear families.
Diabetes 1993;42(1):106-12.
1993: Jonathan C Levy; Carole A Cull; Irene M Stratton; Rury R Holman; RC Turner
[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1993;():123-37.
1992: S E Manley; M E Burton; K E Fisher; Carole A Cull; RC Turner
Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C.
Clinical chemistry 1992;38(11):2294-9.
1992: J T Cook; Andrew T Hattersley; P Christopher; E Bown; BA Barrow; P Patel; J A Shaw; W O Cookson; M A Permutt; RC Turner
Linkage analysis of glucokinase gene with NIDDM in Caucasian pedigrees.
Diabetes 1992;41(11):1496-500.
1992: M Stoffel; P Patel; Y M Dennis Lo; Andrew T Hattersley; A M Lucassen; R Page; J I Bell; Graeme I Bell; RC Turner; james wainscoat
Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes.
Nature genetics 1992;2(2):153-6.
1992: P Patel; Y M Lo; A Hattersley; G I Bell; A Tybjaerg-Hansen; J Nerup; RC Turner; james wainscoat
Linkage analysis of maturity-onset diabetes of the young with microsatellite polymorphisms. No linkage to ADA or GLUT2 genes in two families.
Diabetes 1992;41(8):962-7.
1992: R C Page; K E Harnden; J T Cook; RC Turner
Can life-styles of subjects with impaired glucose tolerance be changed? A feasibility study.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(6):562-6.
1992: A T Hattersley; RC Turner; M Alan Permutt; P Patel; Yukio Tanizawa; K C Chiu; S O'Rahilly; P J Watkins; james wainscoat
Linkage of type 2 diabetes to the glucokinase gene.
Lancet 1992;339(8805):1307-10.
1992: P M Clark; Jonathan C Levy; L Cox; M Burnett; RC Turner; C Nicholas Hales
Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.
Diabetologia 1992;35(5):469-74.
1991: R R Holman; J Steemson; RC Turner
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
Diabetes research (Edinburgh, Scotland) 1991;18(4):149-53.
1991: P Patel; G I Bell; J T Cook; RC Turner; james wainscoat
Multiple restriction fragment length polymorphisms at the GLUT2 locus: GLUT2 haplotypes for genetic analysis of type 2 (non-insulin-dependent) diabetes mellitus.
Diabetologia 1991;34(11):817-21.
1991: Jonathan C Levy; G M Ward; B A Naylor; D H Williamson; RC Turner
Masking of diabetic phenotype on a low-energy diet despite persistence of impaired insulin response.
Metabolism: clinical and experimental 1991;40(10):1009-15.
1991: A S Rudenski; David R Matthews; Jonathan C Levy; RC Turner
Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes.
Metabolism: clinical and experimental 1991;40(9):908-17.
1991: H Flax; David R Matthews; Jonathan C Levy; S W Coppack; RC Turner
No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.
Diabetologia 1991;34(8):570-5.
1991: P Patel; Y M Dennis Lo; G I Bell; RC Turner; james wainscoat
Dinucleotide repeat polymorphism at the human GLUT2 locus.
Nucleic acids research 1991;19(14):4017.
1991: Jonathan C Levy; A Rudenski; M Burnett; R Knight; David R Matthews; RC Turner
Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
Diabetologia 1991;34(7):488-99.
1991: J T Cook; P P Patel; Anne Clark; Jo W M Höppener; Cornelis J M Lips; S Mosselman; Stephen O'Rahilly; R C Page; james wainscoat; RC Turner
Non-linkage of the islet amyloid polypeptide gene with type 2 (non-insulin-dependent) diabetes mellitus.
Diabetologia 1991;34(2):103-8.
1991: RC Turner; Anne Clark; Joseph Levy; Andrew T Hattersley; J C Cook
[Insulin secretion in non-insulin-dependent diabetes].
Journées annuelles de diabétologie de l'Hôtel-Dieu 1991;():141-51.
1990: J M Dunnett; J Steemson; J W Sear; RC Turner; R R Holman
Rapid restoration of normoglycaemia using intravenous insulin boluses.
Diabetes research (Edinburgh, Scotland) 1990;15(4):151-5.
1990: Timothy Davis; E G Bown; RC Turner
Dose-dependent increase in in vitro platelet sensitivity to adenosine-5'-diphosphate in young complication-free diabetic males.
Diabetes research (Edinburgh, Scotland) 1990;15(3):103-7.
1990: RC Turner; Rury R Holman
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
Diabetes care 1990;13(9):1011-20.
1990: Anne Clark; M F Saad; T Nezzer; C Uren; W C Knowler; P H Bennett; RC Turner
Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.
Diabetologia 1990;33(5):285-9.
1990: P Patel; S O'Rahilly; V Buckle; Y Nakamura; RC Turner; james wainscoat
Chromosome 11 allele loss in sporadic insulinoma.
Journal of clinical pathology 1990;43(5):377-8.
1990: RC Turner; A S Rudenski; David R Matthews; Jonathan C Levy; Stephen O'Rahilly; J P Hosker
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
Hormone and metabolic research. Supplement series 1990;24():66-71.
1989: Jonathan C Levy; G Brown; D R Matthews; RC Turner
Hepatic glucose output in humans measured with labeled glucose to reduce negative errors.
The American journal of physiology 1989;257(4 Pt 1):E531-40.
1989: P Patel; S Mosselman; Jo W M Höppener; H S Jansz; Anne Clark; Stephen O'Rahilly; RC Turner; james wainscoat
An RFLP associated with insulinoma amyloid polypeptide locus (IAPP).
Nucleic acids research 1989;17(16):6758.
1989: J P Hosker; A S Rudenski; M A Burnett; David R Matthews; RC Turner
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
Metabolism: clinical and experimental 1989;38(8):767-72.
1989: Stephen O'Rahilly; P Patel; james wainscoat; RC Turner
Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity.
Diabetologia 1989;32(4):266-9.
1989: Stephen O'Rahilly; P Patel; J S Wainscoat; RC Turner
Analysis of the pro-opiomelanocortin gene in non-insulin dependent diabetic families.
Diabetes research (Edinburgh, Scotland) 1989;10(3):125-8.
1989: R Sutton; Derek W R Gray; M Burnett; P McShane; RC Turner; Peter J Morris
Metabolic function of intraportal and intrasplenic islet autografts in cynomolgus monkeys.
Diabetes 1989;38 Suppl 1():182-4.
1988: A Clark; C A Wells; I D Buley; J K Cruickshank; R I Vanhegan; David R Matthews; G J Cooper; R R Holman; RC Turner
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.
Diabetes research (Edinburgh, Scotland) 1988;9(4):151-9.
1988: J P Hosker; M A Burnett; David R Matthews; RC Turner
Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(9):856-60.
1988: Stephen O'Rahilly; R C Trembath; P Patel; D J Galton; RC Turner; J S Wainscoat
Linkage analysis of the human insulin receptor gene in type 2 (non-insulin-dependent) diabetic families and a family with maturity onset diabetes of the young.
Diabetologia 1988;31(11):792-7.
1988: S O O'Rahilly; J P Hosker; A S Rudenski; David R Matthews; M A Burnett; RC Turner
The glucose stimulus-response curve of the beta-cell in physically trained humans, assessed by hyperglycemic clamps.
Metabolism: clinical and experimental 1988;37(10):919-23.
1988: Rury R Holman; RC Turner
Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(6):582-8.
1988: Stephen O'Rahilly; J S Wainscoat; RC Turner
Type 2 (non-insulin-dependent) diabetes mellitus. New genetics for old nightmares.
Diabetologia 1988;31(7):407-14.
1988: P Patel; S O'Rahilly; A Ullrich; RC Turner; J S Wainscoat
A new Sst 1 RFLP associated with human insulin receptor locus.
Nucleic acids research 1988;16(12):5700.
1988: A S Rudenski; J P Hosker; M A Burnett; David R Matthews; RC Turner
The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
Metabolism: clinical and experimental 1988;37(6):526-34.
1988: Stephen O'Rahilly; RC Turner
Early-onset type 2 diabetes vs maturity-onset diabetes of youth: evidence for the existence of two discrete diabetic syndromes.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(3):224-9.
1988: RC Turner; A S Rudenski; J P Hosker; David R Matthews; Jonathan C Levy; Stephen O'Rahilly
CIGMA as a tool in the study of NIDDM.
Progress in clinical and biological research 1988;265():13-26.
1988: A S Rudenski; D R Hadden; A B Atkinson; L Kennedy; David R Matthews; J D Merrett; B Pockaj; RC Turner
Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(1):36-41.
1987: R R Holman; J Steemson; RC Turner
Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
Diabetic medicine : a journal of the British Diabetic Association 1987;4(5):457-62.
1987: B A Naylor; David R Matthews; RC Turner
A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia.
Annals of clinical biochemistry 1987;24 ( Pt 4)():352-63.
1987: S O'Rahilly; M A Burnett; R F Smith; J H Darley; RC Turner
Haemolysis affects insulin but not C-peptide immunoassay.
Diabetologia 1987;30(6):394-6.
1987: A Clark; David R Matthews; B A Naylor; C A Wells; J P Hosker; RC Turner
Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
Diabetes research (Edinburgh, Scotland) 1987;4(2):51-5.
1987: RC Turner; A S Rudenski; R R Holman; David R Matthews; Stephen O'Rahilly
Quantitative modelling of endocrine diseases as exemplified by diabetes.
Clinical endocrinology 1987;26(1):107-16.
1987: R R Holman; J Steemson; P Darling; RC Turner
No glycemic benefit from guar administration in NIDDM.
Diabetes care 1987;10(1):68-71.
1986: S P O'Rahilly; D R Matthews; J P Hosker; RC Turner
Metabolic abnormalities in children of non-insulin dependent diabetics.
British medical journal (Clinical research ed.) 1986;293(6559):1437-8.
1986: J R Howard-Williams; C O Peckar; R R Holman; RC Turner; A J Bron
Quantifying early diabetic retinopathy.
Diabetologia 1986;29(11):761-6.
1986: Stephen O'Rahilly; Z Nugent; A S Rudenski; J P Hosker; M A Burnett; P Darling; RC Turner
Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes.
Lancet 1986;2(8503):360-4.
1986: RC Turner; R R Holman; David R Matthews; Stephen O'Rahilly; A S Rudenski; W J Braund
Diabetes nomenclature: classification or grading of severity?
Diabetic medicine : a journal of the British Diabetic Association 1986;3(3):216-20.
1986: J C Moore; E Bown; M C Outlaw; R Jelfs; R R Holman; RC Turner
Glycosylated haemoglobin: comparison of five different methods, including measurement on capillary blood samples.
Annals of clinical biochemistry 1986;23 ( Pt 1)():85-91.
1986: D B Jones; B Haitas; E G Bown; R D Carter; K Barker; R Jelfs; RC Turner; J I Mann; Robin J Prescott
Platelet aggregation in non-insulin-dependent diabetes is associated with platelet fatty acids.
Diabetic medicine : a journal of the British Diabetic Association 1986;3(1):52-5.
1985: J P Hosker; M A Burnett; E G Davies; E A Harris; RC Turner
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Diabetologia 1985;28(11):809-14.
1985: David R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; RC Turner
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia 1985;28(7):412-9.
1985: J P Hosker; David R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; RC Turner
Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.
Diabetologia 1985;28(7):401-11.
1985: David R Matthews; A S Rudenski; M A Burnett; P Darling; RC Turner
The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression.
Clinical endocrinology 1985;23(1):71-9.
1985: R R Holman; S G Rees; J C Moore; E G Bown; RC Turner
Patient-orientated metered capillary blood collection.
Annals of clinical biochemistry 1985;22 ( Pt 2)():141-3.
1984: G M Ward; B A Naylor; R M Sargent; RC Turner
Abnormal dietary regulation of erythrocyte insulin receptor affinity in non-insulin-dependent diabetes mellitus.
Clinical endocrinology 1984;20(6):671-81.
1984: R R Holman; J Steemson; P Darling; W G Reeves; RC Turner
Human ultralente insulin.
British medical journal (Clinical research ed.) 1984;288(6418):665-8.
1983: D R Matthews; B A Naylor; R G Jones; G M Ward; RC Turner
Pulsatile insulin has greater hypoglycemic effect than continuous delivery.
Diabetes 1983;32(7):617-21.
1983: P Y Poon; Timothy Davis; T L Dornan; RC Turner
Plasma N-acetyl-beta, D-glucosaminidase activities and glycaemia in diabetes mellitus.
Diabetologia 1983;24(6):433-6.
1983: T L Dornan; I L Rhymes; S A Cederholm-Williams; C R Rizza; M B Pepys; A J Bron; RC Turner
Plasma haemostatic factors and diabetic retinopathy.
European journal of clinical investigation 1983;13(3):231-5.
1983: R R Holman; T L Dornan; V Mayon-White; J Howard-Williams; C Orde-Peckar; L Jenkins; J Steemson; R Rolfe; B Smith; D Barbour; Klim McPherson; P Poon; C Rizza; J I Mann; A H Knight; A J Bron; RC Turner
Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study.
Lancet 1983;1(8318):204-8.
1983: RC Turner; M A Phillips; E A Ward
Ultralente based insulin regimens--clinical applications, advantages and disadvantages.
Acta medica Scandinavica. Supplementum 1983;671():75-86.
1982: P Y Poon; T L Dornan; C Orde-Peckar; R Mullins; A J Bron; RC Turner
Blood viscosity, glycaemic control and retinopathy in insulin-dependent diabetes.
Clinical science (London, England : 1979) 1982;63(2):211-6.
1982: G M Ward; R W Simpson; H C Simpson; B A Naylor; J I Mann; RC Turner
Insulin receptor binding increased by high carbohydrate low fat diet in non-insulin-dependent diabetics.
European journal of clinical investigation 1982;12(2):93-6.
1982: T L Dornan; A Ting; C K McPherson; C O Peckar; J I Mann; RC Turner; P J Morris
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics.
Diabetes 1982;31(3):226-31.
1981: G M Ward; R W Simpson; E A Ward; RC Turner
Comparison of two twice-daily insulin regimens: ultralente/soluble and soluble/isophane.
Diabetologia 1981;21(4):383-6.
1981: E A Ward; G M Ward; RC Turner
Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.
British medical journal (Clinical research ed.) 1981;283(6286):278.
1981: G M Ward; A R Rees; B A Naylor; RC Turner
The relationship of erythrocyte insulin receptors to red cell age and to monocyte insulin receptors.
Clinical endocrinology 1981;14(3):269-78.
1981: T L Dornan; C O Peckar; V A Mayon-White; A H Knight; R A Moore; T D Hockaday; A J Bron; RC Turner
Unsuspected hypoglycaemia, haemoglobin A1 and diabetic control.
The Quarterly journal of medicine 1981;50(197):31-8.
1980: E A Ward; M A Phillips; G M Ward; R W Simpson; R Mullins; RC Turner
Clinic- rather than self-monitoring of home blood samples: relevance of day-to-day variability to decision making.
Diabetes care 1980;3(1):171-4.